Glaxosmithkline Pharmaceuticals Q2 Results
- BSE: 500660
- NSE: GLAXO
- ISIN: INE159A01016
- Sector: Biotechnology & Drugs
BSE
2,345.9
-69.30 (-2.87%)
-69.30 (-2.87%)Volume4.41 K
Updated: Mon 25 Nov, 2024 | 15:40:02
NSE
2,341.65-70.15 (-2.91%)
-70.15 (-2.91%)Volume1.12 L
Updated: Mon 25 Nov, 2024 | 15:43:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,010.77 Cr.(24.07%)
- Operating Profit₹309.54 Cr.(44.56%)
- Profit After Tax₹252.50 Cr.(38.49%)
- Operating Margin30.62%(7.99%)
Note: Comparison is on YoY basis
Quarterly - Glaxosmithkline Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,010.77 | 761.66 | -% | 956.99 | -% |
| Selling/ General/ Admin Expenses Total | 150.71 | 165.00 | -% | 145.21 | -% |
| Depreciation/ Amortization | 16.86 | 16.36 | -% | 18.11 | -% |
| Other Operating Expenses Total | 153.86 | 156.66 | -% | 167.85 | -% |
| Total Operating Expense | 701.23 | 616.84 | -% | 685.61 | -% |
| Operating Income | 309.54 | 144.82 | -% | 271.38 | -% |
| Net Income Before Taxes | 343.81 | 180.98 | -% | 299.16 | -% |
| Net Income | 252.50 | 132.25 | -% | 217.51 | -% |
| Diluted Normalized EPS | 14.47 | 7.06 | -% | 12.84 | -% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST